Fukuda-san is perfectly bald, with a luxuriant mustache. His work has been described as “kind of British,” which means he ...
The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...
Ibogaine—a psychoactive plant derivative—has attracted attention for its anti-addictive and anti-depressant properties. But ...
Collagen, the body's most abundant protein, has long been viewed as a predictable structural component of tissues. However, a ...
A research team has developed a revolutionary two-dimensional polyaniline (2DPANI) crystal that overcomes major conductivity ...
Researchers have achieved total chemical synthesis of the psychoactive compound ibogaine and its analogs from pyridine. The discovery will make it easier to explore the therapeutic possibilities of ...